+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
From
Systemic Lupus Erythematosus - Pipeline Review, H2 2020 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 816 Pages
  • Global
From
Bladder Diseases Drug Market - Global Forecast to 2030 - Product Thumbnail Image

Bladder Diseases Drug Market - Global Forecast to 2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
From
Gynecology Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Gynecology Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 100 Pages
  • Global
From
From
From
From
From
Digital Biomarkers Market - Global Outlook & Forecast 2024-2029 - Product Thumbnail Image

Digital Biomarkers Market - Global Outlook & Forecast 2024-2029

  • Report
  • February 2024
  • 352 Pages
  • Global
From
Global Biotechnology - Industry Market Research Report - Product Thumbnail Image

Global Biotechnology - Industry Market Research Report

  • Report
  • April 2025
  • 44 Pages
  • Global
Drug Manufacturing Sector Scorecard - Thematic Intelligence - Product Thumbnail Image

Drug Manufacturing Sector Scorecard - Thematic Intelligence

  • Report
  • October 2022
  • 23 Pages
  • Global
From
Gene Therapy Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Gene Therapy Collaboration and Licensing Deals 2016-2025

  • Report
  • May 2025
  • 450 Pages
  • Global
From
Loading Indicator